Stimcell Energetics (STME) Income towards Parent Company (2016 - 2024)
Stimcell Energetics' (STME) quarterly Income towards Parent Company came in at -$124957.0 in Q2 2024, down 57.41% year-on-year from -$293397.1 in Q2 2023, and down 85.0% quarter-over-quarter from -$67546.0 in Q1 2024.
Stimcell Energetics (STME) Income towards Parent Company (2016 - 2024) Analysis & Trends
Stimcell Energetics' Income towards Parent Company history runs 9 years deep, the most recent figure standing at -$124957.0 for Q2 2024.
- On a quarterly basis, Income towards Parent Company fell 57.41% year-over-year to -$124957.0 in Q2 2024; TTM through Feb 2025 was -$124957.0, a 56.07% increase from a year earlier, with the FY2024 full-year figure at -$2.1 million, up 7.11% from the prior year.
- Income towards Parent Company fell to -$124957.0 in Q2 2024 per STME's latest filing, from -$67546.0 in the prior quarter.
- Across five years, Income towards Parent Company topped out at -$60547.0 in Q4 2023 and bottomed at -$356333.0 in Q1 2020.
- The 5-year median for Income towards Parent Company is -$158623.0 (2022), against an average of -$160431.2.
- Biggest YoY gain for Income towards Parent Company was 78.9% in 2020; the steepest drop was 319.8% in 2020.
- Year by year, Income towards Parent Company stood at -$189336.0 in 2020, then grew by 7.06% to -$175977.0 in 2021, then increased by 18.85% to -$142813.0 in 2022, then surged by 57.6% to -$60547.0 in 2023, then tumbled by 106.38% to -$124957.0 in 2024.
- Per Business Quant, the three latest STME Income towards Parent Company figures stand at -$124957.0 (Q2 2024), -$67546.0 (Q1 2024), and -$60547.0 (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -124,957.00 |
| Feb 29, 2024 | -67,546.00 |
| Nov 30, 2023 | -60,547.00 |
| Aug 31, 2023 | -76,953.00 |
| May 31, 2023 | -79,383.00 |
| Feb 28, 2023 | -118,161.00 |
| Nov 30, 2022 | -142,813.00 |
| Aug 31, 2022 | -154,685.00 |
| May 31, 2022 | -162,561.00 |
| Feb 28, 2022 | -119,489.00 |
| Nov 30, 2021 | -175,977.00 |
| Aug 31, 2021 | -239,352.00 |
| May 31, 2021 | -187,629.00 |
| Feb 28, 2021 | -179,008.00 |
| Nov 30, 2020 | -189,336.00 |
| Aug 31, 2020 | -201,202.00 |
| May 31, 2020 | -251,830.00 |
| Feb 29, 2020 | -356,333.00 |
| Nov 30, 2019 | -303,488.00 |
| Aug 31, 2019 | -245,287.00 |